ABOUT COMPANY
As a research-focused healthcare company, Roche discovers, develops and provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals – from early detection and prevention of diseases to diagnosis, treatment, and treatment monitoring.
Roche Professional Diagnostics (RPD) is the largest Business Area of Roche Diagnostics and a leading supplier of solutions, instrument systems, tests, software and services that help laboratories deliver reliable results more efficiently and cost-effectively. RPD is also strengthening its position as a leader in the growing market for point-of-care testing products to support clinical decision-making in doctors’ offices, emergency rooms and other primary and specialty care settings. Furthermore, RPD develops laboratory information, workflow and data management solutions as well as connectivity components to maximize a laboratory’s efficiency. The primary growth driver of Roche Professional Diagnostics is the immunoassay business. Roche Diagnostics enjoys competitive advantage from its expanding menu of over 100 different tests, the broadest in the industry for a consolidated instrument series.
-
Elecsys® AFP-L3
Elecsys AFP-L3
AFP‑L3 is evaluated as a highly specific marker for HCC.
-
Elecsys® AFP
Elecsys® AFP
Immunoassay for the in vitro quantitative determination of α1‑fetoprotein in human serum and plasma.
-
Elecsys® Troponin T-high sensitive
Elecsys® Troponin T-high sensitive
Enabling fast diagnosis of acute myocardial infarction.
Make a difference when every minute counts.
-
cobas® Liat® System
The cobas® Liat® Analyzer
The small benchtop analyzer is safeguarded by an extensive array of instrument control measures, and automates all nucleic acid testing processes.
-
cobas® HPV
cobas® HPV Test
Delivering confidence with 3-in-1 HPV test results. The link between cervical cancer and Human Papillomavirus (HPV) has become clear over the past few decades — today we know that persistent infection with specific types of HPV account for nearly all cases of cervical cancer.
-
Elecsys® PIVKA-II
Elecsys® PIVKA-II
Elecsys® PIVKA-II is an immunoassay for the quantitative measurement of protein induced by vitamin K absence or antagonist-II (PIVKA‑II) in human serum and plasma. The assay is used as an aid in the diagnosis of hepatocellular carcinoma (HCC). The results must be interpreted in conjunction with other methods in accordance with standard clinical management guidelines
-
Elecsys® GALAD score
Elecsys® GALAD score
FDA grants Breakthrough Device Designation for Roche’s Elecsys GALAD score to support earlier diagnosis of hepatocellular carcinoma
➾ The Elecsys GALAD score aims to support clinicians in diagnosing hepatocellular carcinoma by giving them more timely and accurate information to make earlier interventions
➾ When hepatocellular carcinoma is detected and managed at the very earliest, patient’s 5-year survival rates can increase to over 70%1
➾ Utilizing blood-based biomarkers, as part of the Elecsys GALAD score, is minimally invasive to patients
-
cobas u 411
cobas u 411 urine analyzer
The cobas u 411 urine analyzer is a semi-automated Urine Work Area. It is designed for workloads of approximately 30 – 100 samples per day and can be connected to a barcode reader and sediment terminal. This enables optimized workflows and seamless data exchange.
-
CoaguChek® Pro II
CoaguChek® Pro II
Get immediately actionable results at all points of care.
CoaguChek Pro II system is the clinically vital point-of-care coagulation testing device.
-
cobas b 101
Cobas b 101
One-stop solution for HbA1c, lipids, and CRP testing in the Primary Care Setting
-
cobas b 221
cobas b 221
The cobas b 221 blood gas system sets the gold standard for pleural fluid pH testing
-
cobas h 232 POC system
cobas h 232 POC system
Aiding confident on-the-spot diagnosis and management of patients presenting with signs and symptoms of cardiovascular disease